Medovex Corp. (the “Company”), Steve Gorlin, a Director and the
Co-Chairman of the Board of the Company, Jesse Crowne and NADG
Investment LLLP (NADG) entered into a Fourth Amendment to the
Modification Agreement dated effective as of December 1, 2016
(the Fourth Amendment), which modified and amended that certain
Modification Agreement dated February 16, 2016, as amended by the
Second Amendment to the Modification Agreement dated March 25,
2016, and as further amended by the Third Amendment to the
Modification Agreement dated November 1, 2016 (the Modification
Agreement).

Prior to entering into the Fourth Amendment, Mr. Gorlin was
obligated under the Modification Agreement to purchase from the
Company 571,429 shares of Common Stock at a purchase price of
$1.75 per share (resulting in an aggregate purchase price of
$1,000,000) (the Additional Shares) on or prior to December 1,
2016.

to the Fourth Amendment, Mr. Gorlin (i) assigned to NADG the
obligation to purchase 142,857 of the Additional Shares, for a
total purchase price of $250,000, and (ii) assigned to Mr. Crowne
the obligation to purchase 114,286 of the Additional Shares, for
a total purchase price of $200,000, in each case upon the terms
and subject to the conditions of the Modification Agreement, as
amended by the Fourth Amendment. Mr. Gorlin retained the
obligation to purchase 314,286 of the Additional Shares, for a
total purchase price of $550,000.

The purchase of the Additional Shares by NADG, Mr. Crowne, and
Mr. Gorlin has been completed, such that the Company received an
aggregate of $1,000,000 in exchange for the issuance of an
aggregate of 571,429 shares at a price of $1.75 per share.

In exchange for entering into the Fourth Amendment, Mr. Gorlin
(i) assigned to NADG the right to purchase 62,500 shares of
Common Stock of the Company by assignment of a portion of that
certain Warrant to Purchase Common Stock dated November 9, 2015
issued by the Company to Mr. Gorlin, a copy of which was attached
as Exhibit 10.2 to the Companys Form 10-Q/A filed on November 20,
2015 (as modified by the Modification Agreement, the Gorlin
Warrant), and (ii) assigned to Mr. Crowne the right to purchase
50,000 shares of Common Stock of the Company by assignment of a
portion of the Gorlin Warrant.

The foregoing summary of the Fourth Amendment is qualified in its
entirety by reference to the copy of the amendment included as
Exhibit 4.5 to this Current Report on Form 8-K and incorporated
herein by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.	Description
4.5	Fourth Amendment to Modification Agreement by and between the Company and Steve Gorlin, NADG Investment LLLP, and Jesse Crowne dated November 30, 2016